588. Reproducible and Scalable Production Processes of Recombinant Adeno-Associated Virus Compatible With Current Good Manufacturing Practice

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)36392-4
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

Pharmacology of Recombinant Adeno-Associated Virus Production

Molecular Therapy - Methods and Clinical Development
Molecular MedicineGeneticsMolecular Biology
2018English

Recombinant Adeno-Associated Virus Vectors

Japanese Journal of Thrombosis and Hemostasis
1998English

Insect Cell-Based Recombinant Adeno-Associated Virus Production: Molecular Process Optimization

BioProcessing Journal
2014English

Serotype-Independent Method of Recombinant Adeno-Associated Virus (AAV) Vector Production and Purification

Journal of Nippon Medical School
Medicine
2012English

Rapid and Simplified Purification of Recombinant Adeno-Associated Virus

Journal of Virological Methods
Virology
2012English

Manufacturing of Recombinant Adeno-Associated Viral Vectors for Clinical Trials

Molecular Therapy - Methods and Clinical Development
Molecular MedicineGeneticsMolecular Biology
2016English

Kinetics of Recombinant Adeno-Associated Virus-Mediated Gene Transfer

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2000English

Adeno-Associated Virus: The Naturally Occurring Virus Versus the Recombinant Vector

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2016English

Gene Transfer in the Lung Using Recombinant Adeno-Associated Virus

Current Protocols in Microbiology
MedicineVirologyParasitologyMicrobiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy